Why Patients Are Making The Switch From Mounjaro
Understanding Why Switching From Mounjaro to Wegovy Makes Financial Sense
The decision to switch from Mounjaro to Wegovy often comes down to practical considerations, with cost being a primary factor for many patients. While both treatments are effective GLP-1 receptor agonists designed to support weight management, Wegovy's pricing structure may offer better long-term value for patients committed to ongoing treatment. At maintenance doses, this difference becomes particularly significant over months of continuous therapy.
Beyond cost considerations, some patients find switching from Mounjaro to Wegovy beneficial due to differences in side effect profiles, storage requirements, or simply personal preference. Wegovy's single GLP-1 mechanism differs from Mounjaro's dual GIP/GLP-1 approach, which may suit patients who experienced certain side effects with their previous treatment. Our clinical team at EverydayMeds can guide you through this transition safely and effectively.
Wegovy Pricing and Bundle Options for Switching Patients
When switching from Mounjaro to Wegovy, understanding the cost structure helps you plan your treatment budget effectively. Our single pen prices start at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. These prices reflect the final amount after applying discount codes FIRST40 for new customers or DOSE25 for returning patients at checkout.
For patients switching from Mounjaro to Wegovy who want to secure multiple doses, our bundle options provide convenience and Reliable Supply. The Intro Trio (0.25mg, 0.5mg & 1mg) costs £299.99 and covers your first three months of dose escalation. For those ready for maintenance dosing, the Ultimate Stability Trio provides three 2.4mg pens for £649.99, ensuring uninterrupted treatment without the need for multiple orders.
Clinical Evidence Supporting Wegovy for Weight Management
The STEP clinical trial programme demonstrates Wegovy's effectiveness for long-term weight management. In the landmark STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). For patients switching from Mounjaro to Wegovy, this robust clinical foundation provides confidence in treatment efficacy.
Additional STEP trials show consistent results across different patient populations, with STEP 2 demonstrating approximately clinically studied weight loss in patients with type 2 diabetes, and STEP 5 showing sustained clinically studied weight loss maintained at two years. The recent SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, highlighting Wegovy's benefits beyond weight management for eligible patients.
How Wegovy Works: The GLP-1 Mechanism Explained
When switching from Mounjaro to Wegovy, you're transitioning from a dual hormone approach to a focused GLP-1 receptor agonist mechanism. Wegovy contains semaglutide, which mimics the natural GLP-1 hormone that regulates appetite and blood sugar levels. This prescription-only medicine works by binding to GLP-1 receptors in the brain, reducing appetite signals and promoting feelings of fullness after smaller meals. The treatment may also help reduce food cravings by affecting the brain's reward pathways associated with eating. Unlike Mounjaro's dual GIP/GLP-1 action, Wegovy's singular focus on GLP-1 receptors provides a different therapeutic approach that some patients prefer during their weight management journey.
Simple Ordering Process for Switching Patients
Switching from Mounjaro to Wegovy through EverydayMeds is designed to be straightforward and secure. Begin with our 3-minute online clinical assessment, where you'll provide information about your current treatment and medical history. Our qualified prescribers review your application within 3 working days (or 24 hours with express service) to determine the appropriate starting dose and switching protocol. Once approved, your Wegovy prescription is dispensed from our GPhC-registered pharmacy (#9012878) and delivered via next-day cold-chain courier to maintain the medication's integrity. This seamless process ensures you can transition treatments without interruption to your weight management programme.
Storage Advantages and Practical Considerations
One practical benefit when switching from Mounjaro to Wegovy involves storage flexibility, particularly for patients who travel frequently. Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen device is pre-filled and requires no mixing or preparation, making weekly injections straightforward. Like all GLP-1 treatments, Wegovy requires dose escalation starting at 0.25mg and increasing every four weeks until reaching the 2.4mg maintenance dose. This gradual increase helps minimise potential side effects during the transition period.
Dose Conversion Guidance for Mounjaro to Wegovy Switching
The process of switching from Mounjaro to Wegovy requires careful consideration of dose equivalencies and timing. While both medications work on appetite regulation, their different mechanisms mean direct dose conversion isn't straightforward. Most prescribers recommend starting Wegovy at the standard 0.25mg dose regardless of your previous Mounjaro dose, allowing for proper assessment of tolerance and effectiveness with the new medication.
Timing the switch from Mounjaro to Wegovy typically involves stopping your current treatment and beginning Wegovy within a week to maintain therapeutic continuity. Your prescriber will provide specific guidance based on your individual circumstances, current dose, and treatment response. This professional oversight ensures the switching process is both safe and optimised for continued weight management success.
Complete Your Switch to Wegovy Today
Ready to make the switch from Mounjaro to Wegovy and start saving on your weight management treatment? Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and explore our comprehensive range of Wegovy options. Remember to apply code FIRST40 at checkout if you're a new customer, or DOSE25 for returning patients to access our competitive pricing. Our experienced clinical team is ready to support your transition with professional guidance and reliable supply from our trusted UK pharmacy. Don't let cost or convenience concerns interrupt your weight management journey – make the switch today with confidence and expert support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
